Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications

[1]  G. Remington,et al.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis , 2017, Schizophrenia bulletin.

[2]  X. Tong,et al.  Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1 , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  R. Schwarcz,et al.  The kynurenine pathway and the brain: Challenges, controversies and promises , 2017, Neuropharmacology.

[4]  H. Neuhauser,et al.  Untreated, Uncontrolled, and Apparent Resistant Hypertension: Results of the German Health Examination Survey 2008–2011 , 2016, Journal of clinical hypertension.

[5]  S. S. Sokkar,et al.  Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Leonard A. Mankin.  Update in Hypertension Therapy. , 2016, The Medical clinics of North America.

[7]  C. Fardella,et al.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension , 2016, International journal of molecular sciences.

[8]  W. B. Church,et al.  Kynurenine Aminotransferase Isozyme Inhibitors: A Review , 2016, International journal of molecular sciences.

[9]  A. Muthuraman,et al.  Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain. , 2016, Current drug targets.

[10]  C. Bregonzio,et al.  Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations , 2015, Psychopharmacology.

[11]  L. Malkova,et al.  Blockade of Glutamatergic Transmission in Perirhinal Cortex Impairs Object Recognition Memory in Macaques , 2015, The Journal of Neuroscience.

[12]  Yongnan Li,et al.  Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus , 2015, Molecular and Cellular Neuroscience.

[13]  N. Lazarov,et al.  Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy , 2014, Pharmacology Biochemistry and Behavior.

[14]  C. Bregonzio,et al.  Involvement of the brain renin–angiotensin system (RAS) in the neuroadaptive responses induced by amphetamine in a two-injection protocol , 2014, Behavioural Brain Research.

[15]  Brooke M. Roberts,et al.  Reduction of Brain Kynurenic Acid Improves Cognitive Function , 2014, The Journal of Neuroscience.

[16]  A. Rodriguez-Perez,et al.  Brain renin-angiotensin system and dopaminergic cell vulnerability , 2014, Front. Neuroanat..

[17]  U. Heinemann,et al.  Losartan prevents acquired epilepsy via TGF‐β signaling suppression , 2014, Annals of neurology.

[18]  J. Saavedra,et al.  Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation , 2014, Neuropharmacology.

[19]  P. Nilsson,et al.  Practice guidelines for themanagement of arterial hypertension of the European Society of Hypertension ( ESH ) and the European Society of Cardiology ( ESC ) ESH / ESCTask Force for theManagement of Arterial Hypertension , 2018 .

[20]  I. Hajjar,et al.  Do angiotensin receptor blockers prevent Alzheimer's disease? , 2013, Current opinion in cardiology.

[21]  K. Fuxe,et al.  Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo , 2013, The European journal of neuroscience.

[22]  L. Darlington,et al.  An expanding range of targets for kynurenine metabolites of tryptophan. , 2013, Trends in pharmacological sciences.

[23]  K. Sunagawa,et al.  Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT1 receptor in the rostral ventrolateral medulla of hypertensive rats , 2012, Hypertension Research.

[24]  Ovidiu Constantin Baltatu,et al.  Local renin–angiotensin system and the brain—A continuous quest for knowledge , 2011, Peptides.

[25]  J. Rusted,et al.  Cognitive enhancement following acute losartan in normotensive young adults , 2011, Psychopharmacology.

[26]  N. Garcia-Cairasco,et al.  Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy. , 2010, Clinical science.

[27]  H. Möller,et al.  Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment , 2010, Schizophrenia Research.

[28]  M. Schwab,et al.  Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. , 2010, Rejuvenation research.

[29]  J. Menani,et al.  Importance of angiotensinergic mechanisms for the pressor response to l-glutamate into the rostral ventrolateral medulla , 2010, Brain Research.

[30]  S. Erhardt,et al.  Effects of COX‐1 and COX‐2 inhibitors on the firing of rat midbrain dopaminergic neurons—Possible involvement of endogenous kynurenic acid , 2006, Synapse.

[31]  K. Takeda,et al.  Effects of angiotensin II type 1 receptor antagonist on pressor responses to pulsatile compression of the rostral ventrolateral medulla in rats. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[32]  R. Fogari,et al.  Influence of losartan and atenolol on memory function in very elderly hypertensive patients , 2003, Journal of Human Hypertension.

[33]  P. Schofield,et al.  A Missense Mutation in Kynurenine Aminotransferase-1 in Spontaneously Hypertensive Rats* , 2002, The Journal of Biological Chemistry.

[34]  E. Colombari,et al.  Role of the medulla oblongata in hypertension. , 2001, Hypertension.

[35]  A. Allen,et al.  The physiological role of AT1 receptors in the ventrolateral medulla. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[36]  B. Brew,et al.  Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis , 2000, Redox report : communications in free radical research.

[37]  R. Campos,et al.  Importance of glycinergic and glutamatergic synapses within the rostral ventrolateral medulla for blood pressure regulation in conscious rats. , 1999, Hypertension.

[38]  W. Rascher,et al.  Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. , 1999, European journal of pharmacology.

[39]  R. Schwarcz,et al.  Characterization of rat brain kynurenine aminotransferases I and II , 1997, Journal of neuroscience research.

[40]  J. Chalmers,et al.  KYNURENIC ACID, AN ENDOGENOUS GLUTAMATE ANTAGONIST, IN SHR AND WKY RATS: POSSIBLE ROLE IN CENTRAL BLOOD PRESSURE REGULATION , 1994, Clinical and experimental pharmacology & physiology.

[41]  J. Zhuo,et al.  BLOCKADE BY INTRAVENOUS LOSARTAN OF AT1 ANGIOTENSIN II RECEPTORS IN RAT BRAIN, KIDNEY AND ADRENALS DEMONSTRATED BY IN VITRO AUTORADIOGRAPHY , 1994, Clinical and experimental pharmacology & physiology.

[42]  M. Raizada,et al.  Peptide receptors in astroglia: Focus on angiotensin II and atrial natriuretic peptide , 1994, Glia.

[43]  G. Toney,et al.  Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats. , 1993, Brain research. Developmental brain research.

[44]  D. Averill,et al.  Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. , 1991, The American journal of physiology.

[45]  W. Ganong,et al.  Angiotensinogen production by rat astroglial cells in vitro and in vivo , 1990, Neuroscience.

[46]  J. Chalmers,et al.  Effect of Intrathecal Amino Acid Receptor Antagonists on Basal Blood Pressure and Pressor Responses to Brainstem Stimulation in Normotensive and Hypertensive Rats , 1990, Journal of cardiovascular pharmacology.

[47]  R. Schwarcz,et al.  Rat Brain Slices Produce and Liberate Kynurenic Acid upon Exposure to l‐Kynurenine , 1989, Journal of neurochemistry.

[48]  W. Runciman,et al.  The influence of drug sorption on pharmacokinetic studies of chlormethiazole and lignocaine , 1987, The Journal of pharmacy and pharmacology.

[49]  R. Willette,et al.  Differential regulation of regional vascular resistance by the rostral and caudal ventrolateral medulla in the rat. , 1987, Journal of the autonomic nervous system.

[50]  T. Saruta,et al.  The effects of intracerebroventricular administration of tonin on water drinking and blood pressure in rats. , 1980, Endocrinologia japonica.

[51]  D. Ganten,et al.  Angiotensin-Forming Enzyme in Brain Tissue , 1971, Science.

[52]  Jianyong Li,et al.  Crystal structure of human kynurenine aminotransferase II. , 2008, The Journal of biological chemistry.

[53]  T. Ogihara,et al.  Kynureninase is a novel candidate gene for hypertension in spontaneously hypertensive rats. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[54]  A. Sved,et al.  Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. , 2000, Hypertension.

[55]  K. Jellinger,et al.  Kynurenine metabolism in Alzheimer's disease , 1999, Journal of Neural Transmission.

[56]  Y. Yokota.  [Peptide receptors]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[57]  R. Schwarcz,et al.  Hippocampal kynurenines as etiological factors in seizure disorders. , 1987, Polish journal of pharmacology and pharmacy.